Global study on the accuracy of HER2-low diagnoses among 77 pathologists from 14 countries

Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute shared a recent article by Josef Ruschoff  on X, commenting:

“Global study on the accuracy of HER2-low (vs 0) diagnoses among 77 pathologists from 14 countries 74.6% agreement in the HER2-0 category, which improved after training Though the HER2 categories have already changed, w/ the emergence of HER2 ultralow.”

Title: Global Study on the Accuracy of Human Epidermal Growth Factor Receptor 2-Low Diagnosis in Breast Cancer 

Authors: Josef Rüschoff, Alexander Penner, Ian O Ellis, M Elizabeth Hale Hammond, Annette Lebeau, Robert Y Osamura, Fréderique Penault-Llorca, Federico Rojo, Chirag Desai, Akira Moh, Neil Atkey, Gudrun Baenfer, Andreas H Scheel, Corrado D’Arrigo, Hans-Ulrich Schildhaus, Giuseppe Viale. 

Read more

Source: Paolo Tarantino/X